Profit is profit as usual. I sold off as I got in at IPO. Then got back in when it retraced back in the 60's. We should see another retrace Monday before more results come in.. IMHO
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025